Evolvence India Life Sciences Fund (EILSF) has committed to invest upto Rs. 25 Crore in Anjan Drugs Pvt. Ltd., a Chennai-based pharmaceuticals company specializing in medicines to treat Central Nervous System disorders. Anjan is one of the largest US-FDA approved producers of Divalproex Sodium and various other salts of Valproic Acid.
Other companies that the $150 million EILSF has invested into include Hyderabad-based pharmaceuticals firm Gland Pharma and Bangalore-based oncology hospital firm HealthCare Global Enterprises.